Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,330,143
-$11,005,650 QoQ
Shares Held
5,394,442
-12.0% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$1,235,212
PutShares
147,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. HLN ranks #13 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in HLN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,330,143 | 5,394,442 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $61,335,793 | 6,127,452 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $105,560,308 | 10,441,178 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $79,399,603 | 8,851,684 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $80,478,622 | 7,760,716 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $62,776,654 | 6,100,744 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $59,825,273 | 6,270,993 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $60,125,653 | 5,682,954 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $45,500,093 | 5,508,486 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $40,240,441 | 4,739,746 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $39,619,193 | 4,813,997 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $33,662,928 | 4,041,168 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,235,212 | 147,400 | Put | Defined | 2024-05-14 | |
| 2023-06-30 | $41,635,895 | 4,968,484 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $30,595,443 | 3,758,654 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $49,535,624 | 6,191,953 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $22,793,517 | 3,742,778 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||